A Phase I study evaluating the safety and immunogenicity of MVA85A, a candidate TB vaccine, in HIV-infected adults

Authors

Keywords

Journal

Volume 1, Issue 2, Pages e000223-e000223

Publisher

BMJ

Online

2011-11-16

DOI

10.1136/bmjopen-2011-000223

Discuss science. Find collaborators. Network.

Join a conversation

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now